Cargando…
Antibacterial T6SS effectors with a VRR-Nuc domain are structure-specific nucleases
The type VI secretion system (T6SS) secretes antibacterial effectors into target competitors. Salmonella spp. encode five phylogenetically distinct T6SSs. Here, we characterize the function of the SPI-22 T6SS of Salmonella bongori showing that it has antibacterial activity and identify a group of an...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635880/ https://www.ncbi.nlm.nih.gov/pubmed/36226828 http://dx.doi.org/10.7554/eLife.82437 |
_version_ | 1784824812036685824 |
---|---|
author | Hespanhol, Julia Takuno Sanchez-Limache, Daniel Enrique Nicastro, Gianlucca Gonçalves Mead, Liam Llontop, Edgar Enrique Chagas-Santos, Gustavo Farah, Chuck Shaker de Souza, Robson Francisco Galhardo, Rodrigo da Silva Lovering, Andrew L Bayer-Santos, Ethel |
author_facet | Hespanhol, Julia Takuno Sanchez-Limache, Daniel Enrique Nicastro, Gianlucca Gonçalves Mead, Liam Llontop, Edgar Enrique Chagas-Santos, Gustavo Farah, Chuck Shaker de Souza, Robson Francisco Galhardo, Rodrigo da Silva Lovering, Andrew L Bayer-Santos, Ethel |
author_sort | Hespanhol, Julia Takuno |
collection | PubMed |
description | The type VI secretion system (T6SS) secretes antibacterial effectors into target competitors. Salmonella spp. encode five phylogenetically distinct T6SSs. Here, we characterize the function of the SPI-22 T6SS of Salmonella bongori showing that it has antibacterial activity and identify a group of antibacterial T6SS effectors (TseV1–4) containing an N-terminal PAAR-like domain and a C-terminal VRR-Nuc domain encoded next to cognate immunity proteins with a DUF3396 domain (TsiV1–4). TseV2 and TseV3 are toxic when expressed in Escherichia coli and bacterial competition assays confirm that TseV2 and TseV3 are secreted by the SPI-22 T6SS. Phylogenetic analysis reveals that TseV1–4 are evolutionarily related to enzymes involved in DNA repair. TseV3 recognizes specific DNA structures and preferentially cleave splayed arms, generating DNA double-strand breaks and inducing the SOS response in target cells. The crystal structure of the TseV3:TsiV3 complex reveals that the immunity protein likely blocks the effector interaction with the DNA substrate. These results expand our knowledge on the function of Salmonella pathogenicity islands, the evolution of toxins used in biological conflicts, and the endogenous mechanisms regulating the activity of these toxins. |
format | Online Article Text |
id | pubmed-9635880 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-96358802022-11-05 Antibacterial T6SS effectors with a VRR-Nuc domain are structure-specific nucleases Hespanhol, Julia Takuno Sanchez-Limache, Daniel Enrique Nicastro, Gianlucca Gonçalves Mead, Liam Llontop, Edgar Enrique Chagas-Santos, Gustavo Farah, Chuck Shaker de Souza, Robson Francisco Galhardo, Rodrigo da Silva Lovering, Andrew L Bayer-Santos, Ethel eLife Microbiology and Infectious Disease The type VI secretion system (T6SS) secretes antibacterial effectors into target competitors. Salmonella spp. encode five phylogenetically distinct T6SSs. Here, we characterize the function of the SPI-22 T6SS of Salmonella bongori showing that it has antibacterial activity and identify a group of antibacterial T6SS effectors (TseV1–4) containing an N-terminal PAAR-like domain and a C-terminal VRR-Nuc domain encoded next to cognate immunity proteins with a DUF3396 domain (TsiV1–4). TseV2 and TseV3 are toxic when expressed in Escherichia coli and bacterial competition assays confirm that TseV2 and TseV3 are secreted by the SPI-22 T6SS. Phylogenetic analysis reveals that TseV1–4 are evolutionarily related to enzymes involved in DNA repair. TseV3 recognizes specific DNA structures and preferentially cleave splayed arms, generating DNA double-strand breaks and inducing the SOS response in target cells. The crystal structure of the TseV3:TsiV3 complex reveals that the immunity protein likely blocks the effector interaction with the DNA substrate. These results expand our knowledge on the function of Salmonella pathogenicity islands, the evolution of toxins used in biological conflicts, and the endogenous mechanisms regulating the activity of these toxins. eLife Sciences Publications, Ltd 2022-10-13 /pmc/articles/PMC9635880/ /pubmed/36226828 http://dx.doi.org/10.7554/eLife.82437 Text en © 2022, Hespanhol, Sanchez-Limache et al https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Microbiology and Infectious Disease Hespanhol, Julia Takuno Sanchez-Limache, Daniel Enrique Nicastro, Gianlucca Gonçalves Mead, Liam Llontop, Edgar Enrique Chagas-Santos, Gustavo Farah, Chuck Shaker de Souza, Robson Francisco Galhardo, Rodrigo da Silva Lovering, Andrew L Bayer-Santos, Ethel Antibacterial T6SS effectors with a VRR-Nuc domain are structure-specific nucleases |
title | Antibacterial T6SS effectors with a VRR-Nuc domain are structure-specific nucleases |
title_full | Antibacterial T6SS effectors with a VRR-Nuc domain are structure-specific nucleases |
title_fullStr | Antibacterial T6SS effectors with a VRR-Nuc domain are structure-specific nucleases |
title_full_unstemmed | Antibacterial T6SS effectors with a VRR-Nuc domain are structure-specific nucleases |
title_short | Antibacterial T6SS effectors with a VRR-Nuc domain are structure-specific nucleases |
title_sort | antibacterial t6ss effectors with a vrr-nuc domain are structure-specific nucleases |
topic | Microbiology and Infectious Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635880/ https://www.ncbi.nlm.nih.gov/pubmed/36226828 http://dx.doi.org/10.7554/eLife.82437 |
work_keys_str_mv | AT hespanholjuliatakuno antibacterialt6sseffectorswithavrrnucdomainarestructurespecificnucleases AT sanchezlimachedanielenrique antibacterialt6sseffectorswithavrrnucdomainarestructurespecificnucleases AT nicastrogianluccagoncalves antibacterialt6sseffectorswithavrrnucdomainarestructurespecificnucleases AT meadliam antibacterialt6sseffectorswithavrrnucdomainarestructurespecificnucleases AT llontopedgarenrique antibacterialt6sseffectorswithavrrnucdomainarestructurespecificnucleases AT chagassantosgustavo antibacterialt6sseffectorswithavrrnucdomainarestructurespecificnucleases AT farahchuckshaker antibacterialt6sseffectorswithavrrnucdomainarestructurespecificnucleases AT desouzarobsonfrancisco antibacterialt6sseffectorswithavrrnucdomainarestructurespecificnucleases AT galhardorodrigodasilva antibacterialt6sseffectorswithavrrnucdomainarestructurespecificnucleases AT loveringandrewl antibacterialt6sseffectorswithavrrnucdomainarestructurespecificnucleases AT bayersantosethel antibacterialt6sseffectorswithavrrnucdomainarestructurespecificnucleases |